Literature DB >> 18359621

Distress in palliative care patients: developing patient-centred approaches to clinical management.

Mari Lloyd-Williams1, Joanne Reeve, David Kissane.   

Abstract

It is widely recognised by clinicians that depression is a difficult symptom to identify amongst patients with advanced illness. Many of the symptoms of depression are difficult to elicit in patients who are approaching the end of life. Additionally, many believe that a 'degree' of depression is almost normal as patients approach life's end. More recently the concept of demoralization as a separate entity to depression has been described which can be briefly described as a disorder of meaning and hope. In this paper, we review these diagnoses together with the latest screening tools which can help clinicians to recognise better such pathologies in their patients and discuss interventions that can be utilised to help patients with depression or demoralization to have a better quality of life.

Entities:  

Mesh:

Year:  2008        PMID: 18359621     DOI: 10.1016/j.ejca.2008.02.032

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  12 in total

1.  How family physicians address diagnosis and management of depression in palliative care patients.

Authors:  Franca Warmenhoven; Eric van Rijswijk; Elise van Hoogstraten; Karel van Spaendonck; Peter Lucassen; Judith Prins; Kris Vissers; Chris van Weel
Journal:  Ann Fam Med       Date:  2012 Jul-Aug       Impact factor: 5.166

2.  Creating computable algorithms for symptom management in an outpatient thoracic oncology setting.

Authors:  Mary E Cooley; David F Lobach; Ellis Johns; Barbara Halpenny; Toni-Ann Saunders; Guilherme Del Fiol; Michael S Rabin; Pamela Calarese; Isidore L Berenbaum; Ken Zaner; Kathleen Finn; Donna L Berry; Janet L Abrahm
Journal:  J Pain Symptom Manage       Date:  2013-05-13       Impact factor: 3.612

3.  Depression as a culture-bound syndrome: implications for primary care.

Authors:  Christopher Dowrick
Journal:  Br J Gen Pract       Date:  2013-05       Impact factor: 5.386

4.  Depression, anxiety, and health related quality of life among colorectal cancer survivors.

Authors:  Nayyereh Aminisani; Hosseinali Nikbakht; Mohammad Asghari Jafarabadi; Seyed Morteza Shamshirgaran
Journal:  J Gastrointest Oncol       Date:  2017-02

5.  Depressive disorder in the last phase of life in patients with cardiovascular disease, cancer, and COPD: data from a 20-year follow-up period in general practice.

Authors:  Franca Warmenhoven; Hans Bor; Peter Lucassen; Kris Vissers; Chris van Weel; Judith Prins; Henk Schers
Journal:  Br J Gen Pract       Date:  2013-05       Impact factor: 5.386

Review 6.  A systematic review of cognitive behavioral interventions in advanced cancer.

Authors:  Cathy L Campbell; Lisa C Campbell
Journal:  Patient Educ Couns       Date:  2012-07-12

7.  An Observational Study on the Effects of Delayed Initiation of End-of-Life Care in Terminally ill Young Adults in the Intensive Care Unit.

Authors:  Anirban Hom Choudhuri; Sakshi Duggal; Bhuvna Ahuja; Rajeev Uppal
Journal:  Indian J Palliat Care       Date:  2021-02-17

8.  Unbearable suffering and requests for euthanasia prospectively studied in end-of-life cancer patients in primary care.

Authors:  Cees Dm Ruijs; Gerrit van der Wal; Ad Jfm Kerkhof; Bregje D Onwuteaka-Philipsen
Journal:  BMC Palliat Care       Date:  2014-12-23       Impact factor: 3.234

9.  'Life is still worth living': a pilot exploration of self-reported resources of palliative care patients.

Authors:  Franca Warmenhoven; Peter Lucassen; Mieke Vermandere; Bert Aertgeerts; Chris van Weel; Kris Vissers; Judith Prins
Journal:  BMC Fam Pract       Date:  2016-05-10       Impact factor: 2.497

10.  Symptoms, unbearability and the nature of suffering in terminal cancer patients dying at home: a prospective primary care study.

Authors:  Cees D M Ruijs; Ad J F M Kerkhof; Gerrit van der Wal; Bregje D Onwuteaka-Philipsen
Journal:  BMC Fam Pract       Date:  2013-12-28       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.